Main: +45 31 10 91 91
Fax: +45 77 31 15 09
CVR/VAT no. 31348854
Ordering: +45 29 13 42 24
Are you looking for an exciting job opportunity within a fast-growing field of modern biological sciences? Are you looking for a new career path and would like to make a difference in an innovative and agile organization?
Immudex is a fast-growing biotech company, providing solutions for T-cell immune monitoring within immunotherapy, transplantation, infections disease, and autoimmunity. Based on our proprietary MHC Dextramer® technology, we develop and market research reagents and diagnostic assays, enabling researchers, developers, and clinicians to measure disease-specific T-cell responses.
We are looking for a highly motivated Sales Development Manager for the DACH countries as well as in other assigned territories. You have strong technical knowledge within immunology or genomics with the credibility to effectively consult on solutions, products, and technologies with key decision-makers. You are thrilled about working with a dynamic team of talented professionals and to introduce new products and grow the MHC Dextramer® products in your region. With your strong business acumen, you will build a territory strategic sales plan to deliver on commercial targets and actively build awareness of Immudex’ products. You will report to the Chief Commercial Officer. Location: Preferably Germany, Austria, or Switzerland (home-based position).
We offer a great job with development opportunities in a highly motivating, professional, and friendly environment. You will get the opportunity to spearhead and drive the sale of highly advanced products on a very high scientific level for a highly motivated and educated group of customers. The job will be challenging and rewarding at the same time.
Please apply to this position as soon as possible to firstname.lastname@example.org as we will process applications on an ongoing basis. For more information about the position, please contact Henrik M. Pfundheller, Chief Commercial Officer, at +45 4090 2106 or email@example.com. Your application will be treated in accordance with our policies for processing of personal data, incorporating the General Data Protection Regulation of the EU.
Based in Copenhagen, Denmark, with North American operations based in Fairfax, Virginia, Immudex manufactures MHC Dextramer® for the detection of antigen-specific T cells. Under an agreement with the US Cancer Immunotherapy Consortium (CIC) and the European Cancer Immunotherapy Consortium (CIMT), Immudex also provides MHC Multimer and Elispot proficiency panel services worldwide.
Immudex' MHC Dextramer® products are utilized for the quantification or sorting of antigen-specific T cells in life science research, in-vitro diagnostics, as well as the development of immunotherapeutics and vaccines. The primary focus is research-use-only products for the immune monitoring of immunotherapy development and monitoring of CMV cellular immunity in transplant and other immune-deficient patients. In Europe, the CE marked Dextramer® CMV Kit is approved for in vitro diagnostic use for the quantification of CMV-specific T cells. USA FDA 510(k) clearance for the CMV kit was granted in March 2017. GMP Grade reagents are available.
Our state-of-the-art dCODE Dextramer® reagents enable massive multiplexing of antigen-specific T-cell detection. Detection of over 1000 CD8+ T-cell specificities from a single blood sample has been achieved